Incannex Healthcare
IXHL
2 hedge funds and large institutions have $44.2K invested in Incannex Healthcare in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
50% less funds holding
Funds holding: 4 → 2 (-2)
68% less capital invested
Capital invested by funds: $139K → $44.2K (-$94.9K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$57.6K |
| 2 |
Jane Street
New York
|
-$23.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.43K |
IXHL Hedge Fund Activity: Q1 2023 in Review
2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare (IXHL) for Q1 2023, worth a combined $44.2K — down 68% from $139K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IXHL and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $6.42K. The largest seller was Old Mission Capital, exiting entirely with an estimated $57.6K sold.
- 2 institutional investors held Incannex Healthcare (IXHL) as of Q1 2023, down from 4 in Q4 2022.
- Funds reported $44.2K of Incannex Healthcare stock for Q1 2023, down 68% quarter-over-quarter.
- 0 funds opened new Incannex Healthcare positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest Incannex Healthcare buyer in Q1 2023 was Morgan Stanley, an estimated $6.42K added.
- The largest Incannex Healthcare seller in Q1 2023 was Old Mission Capital, an estimated $57.6K sold.
Based on aggregated 13F filings for Q1 2023.